RISKS FROM DIETARY CALCIUM SUPPLEMENTS
Keywords:
Calcium, Supplements, Osteoporosis, OsteopeniaAbstract
Dietary supplements have a vital role in a modern social life. As general population is concerned about health care on their own and the problem of many essentialnutrition deficiencies in industrialized foods. In Anti-Aging medicine, we found that sub-optimal deficiency of these essential nutrients in long term are associated with many chronic degenerative diseases. As lifespan of human tends to increase, the more chronic degenerative diseases are found especially dementia, cardiovascular disease and osteoporosis. Dietary supplements in a form of multivitamins and minerals are very popular among the general population, especially calcium in order to prevent or treat osteoporosis. But, the way to take dietary supplements to achieve the desirable outcome without any adverse effects, we should clearly understand the true pathological mechanism of each disease. Otherwise, it may lead to undesirable effects.
As a diagnosis of osteopenia and osteoporosis in the elderly, we found that there is less calcium deposit in their bone. But this does not mean that the body is always lack of calcium. Because the deficiency of protein, vitamin C, vitamin D and vitamin K also plays an important role in the foundation of bone synthesis that lead to many minerals including calcium cannot deposit in the bone. So, dietary calcium supplements in the second it ions will increase the risk of extracellular and intracellular calcium which increase the oxidative stress in the cell resulting in cellular toxicity. Furthermore, this leads to chronic degenerative diseases and ectopic calcification and increases the risk of many cancers, too.
References
Alcantara-Martos, T., Delgado-Martinez, A.D., Vega, M.V., and Carrascal, M.T. (2007) Effect of vitamin C on fracture healing in elderly Osteogenic Disorder Shionogi rats. J Bone Joint Surg Br., 89(3), 402-7.
Anekonda, T.S., and Quinn, J.F. (2011). Calcium channel blocking as a therapeutic strategy for Alzheimer’s disease: The case for isradipine. Biochim Biophys Acta., 1812(12), 1584-90.
Bai, Y., Wang, M.Y., Han, Y.H., and Dou, S.W. (2013). Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification. PLoS One, 8(1), e53237.
Bischoff-Ferrari, H.A., Willett, W.C., Wong, J.B., and Giovannucci, E. (2005). Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA., 293(18), 2257-64.
ischoff-Ferrari, H.A., Willett, W.C., Orav, E.J., and Lips, P. (2012). A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med., 367(1), 40-9.
Bolland, M.J., Bacon, C.J., Horne, A.M., and Mason, B.H. (2010). Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr., 91(1), 82-9.
Carinci, F., Pezzetti, F., Spina, A.M., Palmieri, A., and Laino, G. (2005). Effect of Vitamin C on pre-osteoblast gene expression. Arch Oral Biol., 50(5), 481-96.
Choi, K.M., Seo, Y.K., Yoon H.H., and Song, K.Y. (2008). Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng., 105(6), 586-94.
Corona, C., Pensalfini, A., Frazzini, V., and Sensi, S.L. (2011). New therapeutic targets in Alzheimer’s disease: Brain deregulation of calcium and zinc. Cell Death Dis., 2, e176.de Villiers, T.J., and
Stevenson, J.C. (2012). The WHI: The effect of hormone replacement therapy on fracture prevention. Climacteric., 15(3), 263-6.
Embi, A., Scherlag, B.J., Embi, P.J., and Menes, M. (2012). Targeted cellular ionic calcium chelation by oxalates: Implications for the treatment of tumor cells. Cancer Cell Int., 12(1), 51.
Farina, E.K., Kiel, D.P., Roubenoff, R., and Schaefer, E.J. (2012). Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: The Framingham Osteoporosis Study. J Bone Miner Res., 27(5), 1222-30.
Garcia-Prieto, C., Riaz Ahmed, K.B., Chen, Z., and Zhou, Y. (2013). Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis. J Biol Chem., 288(5), 3240-50.
Gudermann, T., and Roelle, S. (2006). Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides. Endocr Relat Cancer., 13(4), 1069-84.
Guzman, R.J. (2007). Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg., Suppl A, A57-63.
Hie, M., and Tsukamoto, I. (2011). Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. J Nutr Biochem., 22(2), 164-71.
Holmberg, L., Wong, Y.N., Tab?r, L., and Ringberg, A. (2013). Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomized study. Br J Cancer., 108(4), 812-9.
Iannetti, P., Parisi, P., Spalice, A., and Ruggieri, M. (2009). Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res., 85(1), 89-95.
Ishii, N., Matsumura, T., Shimoda, S., and Araki, E. (2012). Anti-atherosclerotic potential of dihydropyridine calcium channel blockers. J Atheroscler Thromb., 19(8), 693-704.
Jackson, R.D., LaCroix, A.Z., Gass, M., and Wallace. R.B. (2006). Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med., 354(7), 669-83.
Jacobs, P.C., Gondrie, M.J., van der Graaf, Y., and de Koning, H.J. (2012). Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol., 198(3), 505-11.
Kaufmann, R., and Hollenberg, M.D. (2012). Proteinase-activated receptors (PARs) and calcium signaling in cancer. Adv Exp Med Biol., 740, 979-1000.
Kawamata, H., and Manfredi, G. (2010). Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev., 131(7-8), 517-26.
Kiramijyan, S., Ahmadi, N., Isma’eel, H., and Flores, F. (2013). Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. Am J Cardiol., 111(3), 356-61.
Kurabayashi, M. (2012). Is calcium supplement useful in aged persons? Calcium supplement doesn’t reduce the fracture and vascular risk in aged persons. Clin Calcium., 22(5), 736-9.
Kusama. Y., Kodani, E., Nakagomi, A., and Otsuka, T. (2011). Variant angina and coronary artery spasm: The clinical spectrum, pathophysiology, and management. J Nippon Med Sch., 78(1), 4-12.
Lacativa, P.G., and Farias, M.L. (2010). Osteoporosis and inflammation. Arq Bras Endocrinol Metabol., 54(2), 123-32.
Leveille, S.G., LaCroix, A.Z., Koepsell, T.D., and Beresford, S.A. (1997). Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA. J Epidemiol Community Health., 51(5), 479-85.
Li, J., Wang, P., Yu, S., and Zheng, Z. (2012). Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)/calmodulin-dependent kinase II in retinal capillary endothelial cells. Mol Vis., 18, 2371-9.
Lin, Q., Balasubramanian, K., Fan, D., and Kim, S.J. (2010). Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia., 12(9), 748-54.
Lin, X. Zheng, W., Liu, J., and Zhang, Y. Oxidative stress in malignant melanoma enhances tumor necrosis factor-? secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal., 19(12), 1337-55.
Lips, P., van Schoor, N.M. (2011). The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab., 25(4), 585-91.
Maehata, Y., Takamizawa, S., Ozawa, S., and Izukuri, K. (2007). Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol., 26(5), 371-81.
Mart?nez-Ram?rez, M.J., Palma P?rez, S., Delgado-Mart?nez, A.D., and Mart?nez-Gonz?lez, M.A. (2007). Vitamin C, vitamin B12, folate and the risk of osteoporotic fractures. A case-control study. Int J itamNutr Res., 77(6), 359-68.
Micha?lsson, K., Melhus, H., Warensj? Lemming, E., Wolk, A., & Byberg, L. (2013). Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ., 12, 346.
Mikirova, N., Casciari, J., Rogers, A., and Taylor, P. (2012). Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med., 10, 189.
Montani, D., Savale, L., Natali, D., and Ja?s, X. (2010). Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J., 31(15), 1898-907.
Moon, H.J., Kim, T.H., Byun, D.W., and Park, Y. (2012). Positive correlation between erythrocyte levels of n-3 polyunsaturated fatty acids and bone mass in postmenopausal Korean women with osteoporosis. Ann Nutr Metab., 60(2), 146-53.
Morton, D.J., Barrett-Connor, E.L., and Schneider, D.L. (2001). Vitamin C supplement use and bone mineral density in postmenopausal women. J Bone Miner Res., 16(1), 135-40.
Munday, K., Fulford, A., and Bates, C.J. (2005). Vitamin C status and collagen cross-link ratios in Gambian children. Br J Nutr., 93(4), 501-7.
Nakamura, K., Saito, T., Kobayashi, R., and Oshiki, R. (2011). C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study. Osteoporos Int., 22(7), 2145-50.
Parri, M., and Chiarugi, P. (2013). Redox molecular machines involved in tumor progression. Antioxid Redox Signal., 19(15), 1828-45.
Pasternak, B., Svanstr?m, H., Nielsen, N.M., and Fugger, L. (2012). Use of calcium channel blockers and Parkinson’s disease. Am J Epidemiol., 175(7), 627-35.
Pekkinen, M., Viljakainen, H., Saarnio, E., and Lamberg-Allardt, C. (2012). Vitamin D is a major determinant of bone mineral density at school age. PLoS One., 7(7), e40090.
Poch, M.A., Mehedint, D., Green, D.J., and Payne-Ondracek, R. (2013). The association between calcium channel blocker use and prostate cancer outcome. Prostate., 73(8), 865-72.
Rizzoli, R., Boonen, S., Brandi, M.L., and Bruy?re, O. (2013). Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin., 29(4), 305-13.
Ryder, K.M., Shorr, R.I., Bush, A.J., and Kritchevsky, S.B. (2005). Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc., 53(11), 1875-80.
Ryu, S., McDonnell, K., Choi, H., and Gao, D. (2013). Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell., 23(1), 63-76.
Sahni, S., Hannan, M.T., Gagnon, D., and Blumberg, J. (2009). Protective effect of total and supplemental vitamin C intake on the risk of hip fracture--a 17-year follow-up from the Framingham Osteoporosis Study. Osteoporos Int., 20(11), 1853-61.
Saito, M. (2009). Effect of vitamin K on bone material properties. Clin Calcium., 19(12), 1797-804.
Schwarz, E.C., Qu. B., and Hoth, M. (2013). Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. Biochim Biophys Acta., 1833(7), 1603-11.
Siama, K., Tousoulis, D., Papageorgiou, N., and Siasos, G. (2013). Stable angina pectoris: current medical treatment. Curr Pharm Des., 19(9), 1569-80.
Shimizu, H., Nakagami, H., Yasumasa, N., and Mariana, O.K. (2012). Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel. Hypertens Res., 35(1), 77-81.
Shiraki, M., Shiraki, Y., Aoki, C., and Miura, M. (2000). Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res., 15(3), 515-21.
Torremad?-Barreda, J., Rodr?guez-Tolr?, J., Rom?n-Romera, I., and Padr?-Miquel, A. (2013). Testosteroned eficiency as a risk factor for hip fracture in eldery men. ActasUrol Esp., 37(3), 142-6.
Tangkiatkumjai, M., Boardman, H., and Walker, D.M. (2014). Herbal and dietary supplement use in Bangkok: A survey. J Complement Integr Med., 11(3), 203-11.
van Summeren, M.J., Braam, L.A., and Lilien, M.R. (2009). The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr., 102(8), 1171-8.
Williams, G.R. (2009). Actions of thyroid hormones in bone. Endokrynol Pol., 60(5), 380-8.
Wojcicka, A., Bassett, J.H., and Williams, G.R. (2013). Mechanisms of action of thyroid hormones in the skeleton. Biochim Biophys Acta., 1830(7), 3979-86.
Downloads
Published
How to Cite
Issue
Section
License
Content and information of the article published at Suthiparithat Journal are based on the sole opinions and responsibility of author(s) only. Neither the editorial board involve in......
